Daily pill can double survival time for deadliest cancer, trial shows

A trial suggests a daily pill may roughly double survival for some pancreatic cancer patients.

The treatment is not yet fully approved, but early access is available for eligible patients.

If confirmed, the oral therapy could offer a major new option beyond standard chemotherapy for this deadly cancer.